Article

Pharmacogenetics Determinants of Paxlovid Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in Modulating COVID-19 Patient Outcomes

2024-09-03

Abstract excerpt

This study aimed to investigate the impact of specific single nucleotide polymorphisms (SNPs) on clinical and laboratory outcomes in COVID-19 patients receiving Paxlovid treatment. The primary focus was on genetic variants in IFNAR2, OAS1, OAS3, and ACE2. Laboratory parameters were assessed at admission and discharge, including oxygen saturation, white blood cell count, absolute neutrophil and lymphocyte counts, e...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 678db390-5df3-516c-a33f-1349fb056c94
DOI: 10.20944/preprints202409.0274.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetics Determinants of Paxlovid Response: The Role of IFNAR2, OAS1, OAS3, and ACE2 in Modulating COVID-19 Patient OutcomesDOI 10.20944/preprints202409.0274.v1Read

Association of <i>IFNAR2</i> rs2236757 and <i>OAS3</i> rs10735079 polymorphisms with susceptibility to COVID-19 infection and severitySemantic proximity Read

Association of IFNAR2 rs2236757 and OAS3 rs10735079 Polymorphisms with Susceptibility to COVID-19 Infection and Severity in PalestineSemantic proximity Read

Pharmacogenomic Study of SARS-CoV-2 Treatments: Identifying Polymorphisms Associated with Treatment Response in COVID-19 PatientsSemantic proximity Read

Polymorphisms in ACE1, TMPRSS2, IFIH1, IFNAR2, and TYK2 Genes Are Associated with Worse Clinical Outcomes in COVID-19.Semantic proximity Read

Effectiveness of Paxlovid - a reviewSemantic proximity Read

ABO gene polymorphism and COVID-19 severity: The impact on haematological complications, inflammatory markers, and lung lesions.Semantic proximity Read

Annual SZ® A Novel Formulation For COVID-19 Therapy Clinical Trial StudiesSemantic proximity Read

Clinical efficacy of sofosbuvir/daclatasvir in patients with COVID-19: a systematic review and meta-analysis of randomized trials.Semantic proximity Read

Genomic Insight into the COVID-19 Severity in MAFLD Patients: A Single-Center Prospective Cohort StudySemantic proximity Read

Gene Variants of the OAS/RNase L Pathway and Their Association with Severity of Symptoms and Outcome of SARS-CoV-2 InfectionSemantic proximity Read

Human genetic polymorphisms and risk of viral infection after solid organ transplantation.Semantic proximity Read

Comparative effectiveness of Paxlovid versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients: observational cohort study using the OpenSAFELY platformSemantic proximity Read